SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABS
· Real-Time Price · USD
2.86
0.28 (10.85%)
At close: Sep 18, 2025, 3:59 PM
2.81
-1.92%
Pre-market: Sep 19, 2025, 06:15 AM EDT
SAB Biotherapeutics Earnings Surprise
SAB Biotherapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
Earnings Chart
History
| Period | Date | EPS | EPS Est. | Rev | Rev Est. |
|---|---|---|---|---|---|
| FY25 Q1 | May 09, 2025 | -0.560 | -0.720 | 0.000 | 260K |
| FY24 Q4 | Mar 28, 2025 | -1.23 | -1.210 | 114.7K | 120K |
| FY24 Q3 | Nov 06, 2024 | -1.120 | -1.070 | 0.000 | 170K |
| FY24 Q2 | Aug 08, 2024 | -0.790 | -1.030 | 263.14K | n/a |
| FY24 Q1 | May 20, 2024 | -0.540 | -0.460 | 944.58K | n/a |
| FY23 Q4 | Mar 29, 2024 | -3.840 | -0.620 | 305.01K | n/a |
| FY23 Q3 | Nov 13, 2023 | -1.000 | -1.200 | 1.27M | 20K |
| FY23 Q2 | Aug 21, 2023 | -1.400 | 85.52K | n/a | |
| FY23 Q1 | May 16, 2023 | -1.500 | -0.800 | 581.1K | 2.36M |
| FY22 Q4 | Apr 14, 2023 | -1.800 | -0.300 | 2.16M | 6.5M |
| FY22 Q3 | Nov 15, 2022 | -1.600 | -1.600 | 3.59M | 6.85M |